NAMS Management Of Symptomatic Vulvovaginal Atrophy Guideline Summary

Guideline Central highly recommends you use Google Chrome while using this site.

For optimal experience please use Google Chrome.

Thank you.

By creating an account, I agree to receive occasional communications from Guideline Central. I understand I can opt out of these communications at any time by visiting my account page.

Already have an account? Login

Title

Management Of Symptomatic Vulvovaginal Atrophy

Authoring Organization

Publication Month/Year

March 1, 2014

Supplemental Implementation Tools

Patient Information

Document Type

Consensus

External Publication Status

Published

Country of Publication

Inclusion Criteria

Female, Adult, Older adult

Health Care Settings

Ambulatory, Hospital, Outpatient

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Assessment and screening, Management, Treatment

Diseases/Conditions (MeSH)

D008593 - Menopause, D017698 - Postmenopause, D004414 - Dyspareunia

Keywords

menopause, postmenopausal, vulvovaginal atrophy (VVA), vaginal dryness, vagainal estrogen, Ospemifene, Dyspareunia

Source Citation

Management Of Symptomatic Vulvovaginal Atrophy. Menopause. 2014; 20(9): 888-902.

Login

Forgot Password

Register